Cargando…
Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy
Glioma is a rapidly growing and aggressive primary malignant tumor of the central nervous system that can diffusely invade the brain tissue around, and the prognosis of patients is not significantly improved by traditional treatments. One of the most general posttranslational modifications of protei...
Autores principales: | Yue, Juan, Huang, Roujie, Lan, Zehao, Xiao, Bo, Luo, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214721/ https://www.ncbi.nlm.nih.gov/pubmed/37231524 http://dx.doi.org/10.1186/s40364-023-00491-8 |
Ejemplares similares
-
Investigational Microbiological Therapy for Glioma
por: Wang, Jing, et al.
Publicado: (2022) -
Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies
por: Khan, Thahomina, et al.
Publicado: (2021) -
Abnormal glycosylation in Joubert syndrome type 10
por: Kane, Megan S., et al.
Publicado: (2017) -
The role of integrins in glioma biology and anti-glioma therapies
por: Roth, Patrick
Publicado: (2015) -
Pediatric Liver Disease Patients and Secondary Glycosylation Abnormalities
por: Bogdańska, Anna, et al.
Publicado: (2021)